長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4571】NANO MRNA

【4571】NANO MRNA
創薬ベンチャー
類似企業：
【業界1位】 小野薬品工業
【売上同水準】 アンジェス ヘリオス


東証グロース
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.03 2024/11/14 修正予 108 ↑ +111.8% +111.8% -893 ↑ +28.1% +28.1% -856 ↑ +28.2% +28.2% -994 ↑ +17.6% +17.6%
2025.03 2024/08/09 Q1予 51 → 0.0% 0.0% -1,242 → 0.0% 0.0% -1,192 → 0.0% 0.0% -1,206 → 0.0% 0.0%
2025.03 2024/05/14 当初予 51 - - - -1,242 - - - -1,192 - - - -1,206 - - -
2024.03 2024/05/14 実 135 → 0.0% -5.6% -864 ↑ +11.7% +28.7% -749 ↑ +15.2% +35.7% -780 ↑ +17.5% +34.9%
2024.03 2024/02/14 Q3予 135 ↓ -5.6% -5.6% -979 ↑ +19.2% +19.2% -883 ↑ +24.2% +24.2% -945 ↑ +21.2% +21.2%
2024.03 2023/11/10 Q2予 143 → 0.0% 0.0% -1,212 → 0.0% 0.0% -1,165 → 0.0% 0.0% -1,199 → 0.0% 0.0%
2024.03 2023/05/12 当初予 143 - - - -1,212 - - - -1,165 - - - -1,199 - - -
2023.03 2023/05/12 実 202 ↑ +9.8% +9.8% -1,246 ↑ +19.1% +19.1% -1,104 ↑ +24.5% +24.5% -1,310 ↑ +10.9% +10.9%
2023.03 2023/02/14 Q3予 184 → 0.0% 0.0% -1,540 → 0.0% 0.0% -1,463 → 0.0% 0.0% -1,471 → 0.0% 0.0%
2023.03 2022/11/11 Q2予 184 → 0.0% 0.0% -1,540 → 0.0% 0.0% -1,463 → 0.0% 0.0% -1,471 → 0.0% 0.0%
2023.03 2022/08/10 Q1予 184 → 0.0% 0.0% -1,540 → 0.0% 0.0% -1,463 → 0.0% 0.0% -1,471 → 0.0% 0.0%
2023.03 2022/05/12 当初予 184 - - - -1,540 - - - -1,463 - - - -1,471 - - -
2022.03 2022/05/12 実 264 ↑ +15.8% +15.8% -2,061 ↓ -14.2% -14.2% -1,925 ↓ -9.9% -9.9% -1,881 ↓ -8.5% -8.5%
2022.03 2022/02/10 Q3予 228 → 0.0% 0.0% -1,804 → 0.0% 0.0% -1,751 → 0.0% 0.0% -1,734 → 0.0% 0.0%
2022.03 2021/11/12 Q2予 228 → 0.0% 0.0% -1,804 → 0.0% 0.0% -1,751 → 0.0% 0.0% -1,734 → 0.0% 0.0%
2022.03 2021/08/13 Q1予 228 → 0.0% 0.0% -1,804 → 0.0% 0.0% -1,751 → 0.0% 0.0% -1,734 → 0.0% 0.0%
2022.03 2021/05/13 当初予 228 - - - -1,804 - - - -1,751 - - - -1,734 - - -
2021.03 2021/05/13 実 313 ↓ -7.4% -7.4% -1,302 ↑ +12.9% +12.9% -1,278 ↑ +14.6% +14.6% -2,835 ↑ +6.8% -90.3%
2021.03 2021/02/10 Q3予 338 → 0.0% 0.0% -1,495 → 0.0% 0.0% -1,496 → 0.0% 0.0% -3,043 → 0.0% -104.2%
2021.03 2020/11/12 Q2予 338 → 0.0% 0.0% -1,495 → 0.0% 0.0% -1,496 → 0.0% 0.0% -3,043 ↓ -104.2% -104.2%
2021.03 2020/08/12 Q1予 338 → 0.0% 0.0% -1,495 → 0.0% 0.0% -1,496 → 0.0% 0.0% -1,490 → 0.0% 0.0%
2021.03 2020/05/13 当初予 338 - - - -1,495 - - - -1,496 - - - -1,490 - - -
2020.03 2020/05/13 実 552 → 0.0% -5.0% -1,105 ↑ +3.3% +27.3% -1,144 ↑ +3.2% +25.5% -2,009 ↑ +1.9% -38.6%
2020.03 2020/04/02 修正予 552 ↓ -5.0% -5.0% -1,143 ↑ +24.8% +24.8% -1,182 ↑ +23.0% +23.0% -2,047 ↓ -41.2% -41.2%
2020.03 2020/02/14 Q3予 581 → 0.0% 0.0% -1,520 → 0.0% 0.0% -1,536 → 0.0% 0.0% -1,450 → 0.0% 0.0%
2020.03 2019/11/14 Q2予 581 → 0.0% 0.0% -1,520 → 0.0% 0.0% -1,536 → 0.0% 0.0% -1,450 → 0.0% 0.0%
2020.03 2019/08/09 Q1予 581 → 0.0% 0.0% -1,520 → 0.0% 0.0% -1,536 → 0.0% 0.0% -1,450 → 0.0% 0.0%
2020.03 2019/05/14 当初予 581 - - - -1,520 - - - -1,536 - - - -1,450 - - -
2019.03 2019/05/14 実 496 ↑ +4.6% +121.4% -1,802 ↑ +18.1% +26.4% -1,774 ↑ +18.9% +27.2% -1,808 ↑ +19.5% +27.5%
2019.03 2019/02/13 Q3予 474 → 0.0% +111.6% -2,199 → 0.0% +10.2% -2,188 → 0.0% +10.3% -2,245 → 0.0% +10.0%
2019.03 2018/11/09 Q2予 474 → 0.0% +111.6% -2,199 → 0.0% +10.2% -2,188 → 0.0% +10.3% -2,245 → 0.0% +10.0%
2019.03 2018/08/13 修正予 474 ↑ +111.6% +111.6% -2,199 ↑ +10.2% +10.2% -2,188 ↑ +10.3% +10.3% -2,245 ↑ +10.0% +10.0%
2019.03 2018/08/10 Q1予 224 → 0.0% 0.0% -2,449 → 0.0% 0.0% -2,438 → 0.0% 0.0% -2,495 → 0.0% 0.0%
2019.03 2018/05/15 当初予 224 - - - -2,449 - - - -2,438 - - - -2,495 - - -
2018.03 2018/05/15 実 259 ↑ +1.6% +31.5% -5,351 ↓ -13.2% -99.4% -5,304 ↓ -14.1% -103.5% -5,416 ↓ -13.1% -97.2%
2018.03 2018/03/20 修正予 255 ↑ +29.4% +29.4% -4,726 ↑ +1.2% -76.1% -4,648 ↑ +1.2% -78.4% -4,789 ↑ +1.2% -74.3%
2018.03 2018/02/14 Q3予 197 → 0.0% 0.0% -4,784 → 0.0% -78.2% -4,706 → 0.0% -80.6% -4,847 → 0.0% -76.4%
2018.03 2017/11/10 Q2予 197 → 0.0% 0.0% -4,784 → 0.0% -78.2% -4,706 → 0.0% -80.6% -4,847 → 0.0% -76.4%
2018.03 2017/11/06 修正予 197 → 0.0% 0.0% -4,784 ↓ -78.2% -78.2% -4,706 ↓ -80.6% -80.6% -4,847 ↓ -76.4% -76.4%
2018.03 2017/08/10 Q1予 197 → 0.0% 0.0% -2,684 → 0.0% 0.0% -2,606 → 0.0% 0.0% -2,747 → 0.0% 0.0%
2018.03 2017/05/15 当初予 197 - - - -2,684 - - - -2,606 - - - -2,747 - - -
2017.03 2017/05/15 実 218 ↑ +1.9% +19.8% -2,712 ↓ -0.8% +21.4% -2,619 ↓ -1.5% +23.2% -2,676 ↓ -1.1% +23.0%
2017.03 2017/04/05 修正予 214 → 0.0% +17.6% -2,690 ↑ +21.3% +22.1% -2,581 ↑ +23.6% +24.3% -2,647 ↑ +23.1% +23.8%
2017.03 2017/03/21 修正予 214 ↑ +17.6% +17.6% -3,420 ↑ +0.9% +0.9% -3,378 ↑ +0.9% +0.9% -3,443 ↑ +0.9% +0.9%
2017.03 2017/02/14 Q3予 182 → 0.0% 0.0% -3,452 → 0.0% 0.0% -3,410 → 0.0% 0.0% -3,475 → 0.0% 0.0%
2017.03 2016/11/11 Q2予 182 → 0.0% 0.0% -3,452 → 0.0% 0.0% -3,410 → 0.0% 0.0% -3,475 → 0.0% 0.0%
2017.03 2016/08/10 Q1予 182 → 0.0% 0.0% -3,452 → 0.0% 0.0% -3,410 → 0.0% 0.0% -3,475 → 0.0% 0.0%
2017.03 2016/05/12 当初予 182 - - - -3,452 - - - -3,410 - - - -3,475 - - -
2016.03 2016/05/12 実 243 ↑ +6.6% +77.4% -2,082 ↑ +19.1% +21.9% -2,381 ↑ +5.7% +9.0% -2,537 ↑ +5.4% +8.5%
2016.03 2016/03/24 修正予 228 ↑ +26.7% +66.4% -2,575 ↑ +1.8% +3.4% -2,526 ↑ +1.9% +3.5% -2,681 ↑ +1.8% +3.3%
2016.03 2016/03/16 修正予 180 ↑ +31.4% +31.4% -2,623 ↑ +1.6% +1.6% -2,574 ↑ +1.6% +1.6% -2,729 ↑ +1.6% +1.6%
2016.03 2016/02/12 Q3予 137 → 0.0% 0.0% -2,666 → 0.0% 0.0% -2,617 → 0.0% 0.0% -2,772 → 0.0% 0.0%
2016.03 2015/11/12 Q2予 137 → 0.0% 0.0% -2,666 → 0.0% 0.0% -2,617 → 0.0% 0.0% -2,772 → 0.0% 0.0%
2016.03 2015/08/12 Q1予 137 - - - -2,666 - - - -2,617 - - - -2,772 - - -
2015.03 2015/02/13 Q3予 560 → 0.0% +69.7% -1,428 → 0.0% +27.0% -1,029 → 0.0% +47.4% -1,070 → 0.0% +45.7%
2015.03 2014/11/11 Q2予 560 ↑ +69.7% +69.7% -1,428 ↑ +27.0% +27.0% -1,029 ↑ +47.4% +47.4% -1,070 ↑ +45.7% +45.7%
2015.03 2014/05/13 当初予 330 - - - -1,955 - - - -1,955 - - - -1,970 - - -
2014.03 2014/05/13 実 472 ↑ +0.2% +0.2% -1,123 ↑ +0.3% +0.3% -1,094 ↑ +0.9% +0.9% -1,113 ↑ +0.8% +0.8%
2014.03 2014/04/02 当初予 471 - - - -1,126 - - - -1,104 - - - -1,122 - - -
シェア ツイート
ページトップへ戻る